LelandLMethenyIIIMD

PubMed

• 14 citations
  Socioeconomic Factors and Survival of Multiple Myeloma Patients.
  Kamal Chamoun, Amin Firoozmand, Paolo Caimi, Pingfu Fu, Shufen Cao
  Cancers. 2021-02-03
• 11 citations
  A Phase I Study to Determine the Maximum Tolerated Dose of ex Vivo Expanded Natural Killer Cells Derived from Unrelated, HLA-Disparate Adult Donors.
  Folashade Otegbeye, Brenda Cooper, Paolo Caimi, Kayla Zamborsky, Jane Reese-Koc
  Transplantation and Cellular Therapy. 2022-05-01
• 150 citations
  Chronic myeloid leukemia, version 2.2021
  Michael W. Deininger, Neil P. Shah, Jessica K. Altman, Ellin Berman, Ravi Bhatia
  Journal of the National Comprehensive Cancer Network. 2020-10-01

Journal Articles

• NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 12017  
  Pallera A, Altman JK, Berman E, Abboud CN, Bhatnagar B, Curtin P, DeAngelo DJ, Gotlib J, Hagelstrom RT, Hobbs G, Jagasia M, Kantarjian HM, Kropf P, Metheny L, Moore JO..., J Natl Compr Canc Netw, 1/1/2016
• Intra-osseous Co-transplantation of CD34-selected Umbilical Cord Blood and Mesenchymal Stromal Cells  
  Metheny L, Eid S, Lingas K, Reese J, Meyerson H, Tong A, de Lima M, Huang AY, Hematol Med Oncol, 1/1/2016
• Human mesenchymal stem cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation  
  Auletta JJ, Eid SK, Wuttisarnwattana P, Silva I, Metheny L, Keller MD, Guardia-Wolff R, Liu C, Wang F, Bowen T, Lee Z, Solchaga LA, Ganguly S, Tyler M, Wilson DL, Cook..., Stem Cells, 1/1/2015
• Cord blood transplantation: can we make it better?  
  Metheny L, de Lima M, Caimi P, Frontiers in Oncology, 1/1/2013
• Multiple Myeloma Presenting As Mandibular Ill-Defined Radiolucent Lesion With Numb Chin Syndrome: A Case Report  
  Elias HG, Scott J, Metheny L, Quereshy FA, J Oral Maxillofac Surg, 1/1/2009
• Join now to see all

Books/Book Chapters

• Umbilical Cord Blood Banking and Transplantation. 
  Chapter: Cord Blood ex vivo expansion. 
  Caimi PF, Metheny L, de Lima MEditors: Karen Ballen.Humana Press/ Springer, New York, NY2014

Abstracts/Posters

• Lymphoma-Specific Venous Thromboembolism Score (LyV-Score): Use of Lymphoma Subtype to Refine Risk Prediction
  Leland Metheny III, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Phase 1 Study of on Site Manufactured Anti-CD19 CAR-T Cells: Responses in Subjects with Rapidly Progressive Refractory Lymphomas
  Leland Metheny III, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Preclinical Studies and Phase I Trial of Vactosertib in Combination with Pomalidomide in Relapsed Multiple Myeloma: A Corticosteroid-Free Approach By Targeting TGF-_ S...
  Leland Metheny III, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Filgrastim Administered after Early Assessment Bone Marrow Biopsy during 7+3 Induction Therapy for Acute Myeloid Leukemia Reduces Length of Hospital Stay
  Leland Metheny III, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Cardiovascular Toxicity after Therapy for Diffuse Large B Cell Lymphoma Occurs Early and Results in Decreased Overall Survival.
  Ayyappan S, Diamond A, Gupta V, Cooper B, Tomlinson BK, Malek E, Metheny L, Lazarus HM, Gerson SL, De Lima M, Caimi P, Blood; ASH Annual Meeting Abstracts, San Diego, CA, 1/3/2016
• Venous Thromboembolic Events in Diffuse Large B Cell Lymphoma Patients: Risk Factors and Outcomes.
  Ayyappan S, Diamond A, Gupta V, Cooper B, Tomlinson BK, Malek E, Metheny L, Lazarus HM, Gerson SL, De Lima M, Caimi P, Blood; ASH Annual Meeting Abstracts, San Diego, CA, 1/3/2016
• Treatment of Diffuse Large Cell Lymphoma (DLBCL) Patients Older Than 75 Years: Higher Mortality and Risk of Complications without Increased Risk of Relapse after Treat...
  Diamond A, Ayyappan S, Pinto R, Cooper B, Tomlinson BK, Malek E, Metheny L, Lazarus HM, Gerson SL, De Lima M, Caimi, Blood; ASH Annual Meeting Abstracts, San Diego, CA, 1/3/2016
• Intra-Osseous Co-Transplantation of CD34-Selected Umbilical Cord Blood and Mesenchymal Stem Cells.
  Metheny L, de Lima M, Gerson S, Eid S, Huang AY, Blood; ASH Annual Meeting Abstracts, San Francisco, CA, 1/6/2014
• Human Multipotent Adult Progenitor Cells Effectively reduce GVHD While Preserving Graft-Versus-Leukemia Activity After Allogeneic BMT.
  Metheny L, Eid S, Keller M, Sullivant K, Lee ZH, Wilson D, Auletta J, Vant Hof W, Cooke KR, ASBMT; BMT Tandem Meetings, San Diego, CA, 1/1/2012
• Join now to see all

Lectures

• Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic Leukemia 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Comparison of Pegfilgrastim and Filgrastim to Prevent Neutropenic Fever during Consolidation with High Dose Cytarabine for Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• The Direction of KIR Ligand Incompatibility Is Associated with Graft Failure and May Predict the Dominant Donor Following Double Umbilical Cord Blood Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Impact of Maintenance Therapy on Nature of First Relapse in Multiple Myeloma Patients Underwent Autologous Stem Cell Transplant 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Introduction to Stem Cell Transplant II 
  1/1/2016
• Novel Approaches To Allogeneic Stem Cell Transplantation 
  1/1/2016
• Donor Characteristics in Stem Cell Transplant 
  1/1/2015
• Introduction to Stem Cell Transplant I 
  1/1/2015
• Join now to see all